Interleukin-12 as adjuvant in peptide vaccines.
O'Toole
M
M
Genetics Institute, Cambridge, Massachusetts 02140, USA.
Wooters
J
J
Brown
E
E
Swiniarski
H
H
Cull
G
G
Leger
L
L
Herrmann
S
S
D000276:Adjuvants, Immunologic; D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D007111:Immunity, Cellular; D007252:Influenza Vaccines / Q000276:immunology*; D018664:Interleukin-12 / Q000627:therapeutic use*; D051379:Mice; D008809:Mice, Inbred C3H; D010455:Peptides / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000956:Antigens, Viral; D015395:Histocompatibility Antigens Class I; D007252:Influenza Vaccines; D010455:Peptides; D018664:Interleukin-12